Comparison of Wrist Splint Positions in Carpal Tunnel Syndrome
Evaluation of the Effectiveness of Splint Use in Different Wrist Positions in the Treatment of Carpal Tunnel Syndrome: A Single-Blind, Randomized, Controlled Trial
1 other identifier
interventional
108
0 countries
N/A
Brief Summary
Carpal tunnel syndrome (CTS) is the most common nerve compression syndrome. It develops as a result of the compression of the median nerve while passing through the osteofibrous structure of the carpal tunnel located at the wrist. Sensory symptoms are the most prominent feature of CTS. These symptoms are observed as pain, paresthesia, and decreased sensory sensitivity. As motor symptoms, thumb abduction and opposition are primarily affected. In advanced cases, atrophy develops in the thenar muscles. Patients may describe weakness as difficulty in writing, opening jars, buttoning, or grasping objects. The diagnosis is made by fulfilling both clinical and electrophysiological diagnostic criteria. CTS has both conservative and surgical treatment options. Conservative treatment includes splinting, physical therapy modalities, and injection options, and it is preferred in mild and moderate cases. Among non-surgical treatment options, splint use is a commonly applied intervention; however, there is no consensus regarding its effectiveness, the optimal wrist position during use, or the duration and frequency of splint application. A total of 108 hands from patients aged 18 to 55 years diagnosed with CTS will be included in this study and randomized into three groups. All groups will be given an education and exercise program. The first group will use a wrist splint fixed at 15° flexion; the second group at neutral position; and the third group at 20° extension, to be worn only at night for eight weeks. Patients will be evaluated before treatment, immediately after treatment, and two months after the end of treatment using measures of pain- numbness severity, functional status, motor and sensory examination findings, and nerve conduction studies. What makes this study unique is that it evaluates the effects of splints that stabilize the wrist at different angles together with electrophysiological findings. A review of the literature shows that while some studies have examined and compared the effects of splints fixed at different wrist angles on symptoms, functional status, and physical examination findings, there is no study that evaluates these effects along with electrophysiological findings. Therefore, this study, which will compare the effectiveness of splints at different angles, is expected to contribute to the literature. The expected outcomes of this research are that one or more types of splints used in the conservative treatment of CTS will provide improvements in symptom severity, functional status, sensory and motor physical examination findings, and electrophysiological evaluation findings at the end of treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2026
Typical duration for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2026
CompletedFirst Submitted
Initial submission to the registry
March 3, 2026
CompletedFirst Posted
Study publicly available on registry
March 9, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2029
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 1, 2029
March 12, 2026
March 1, 2026
2.8 years
March 3, 2026
March 10, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Nerve Conduction Study (NCS)
Median motor distal latency and conduction velocity and second finger recorded median sensory distal latency and conduction velocity will be measured in all individuals. In addition to routine conduction examinations, fourth finger recorded median-ulnar peak latency comparison examinations will also be made.
Baseline and sixteen week of intervention
Secondary Outcomes (8)
Visual Pain Scale (VAS)
Baseline, eight week of intervention, sixteen week of intervention
Boston Carpal Tunnel Syndrome Questionnaire (BCTSQ)
Baseline, eight week of intervention, sixteen week of intervention
Semmes Weinstein Monofilament Test (SWMT)
Baseline, eight week of intervention, sixteen week of intervention
Two Point Discrimination Test (TPDT)
Baseline, eight week of intervention, sixteen week of intervention
Hand Grip Force
Baseline, eight week of intervention, sixteen week of intervention
- +3 more secondary outcomes
Study Arms (3)
15° Flexion Wrist Splint Group
ACTIVE COMPARATORNeutral Wrist Splint Group
ACTIVE COMPARATOR20° Extension Wrist Splint Group
ACTIVE COMPARATORInterventions
Participants will wear wrist splint fixed at 15° of wrist flexion during nighttime only for eight weeks.
Participants will wear a wrist splint maintaining the wrist in a neutral position during nighttime only for eight weeks.
Participants will wear a wrist splint fixed at 20° of wrist extension during nighttime only for eight weeks.
All participants will also receive a standardized education.
All participants will also receive a standardized exercise program.
Eligibility Criteria
You may qualify if:
- Diagnosis of mild to moderate carpal tunnel syndrome confirmed by electrophysiological studies performed within the last year.
- Clinical findings consistent with carpal tunnel syndrome.
- Age between 18 and 65 years.
You may not qualify if:
- \<18 years or \>65 years
- Thenar atrophy
- Surgery history for CTS
- Steroid injection for CTS
- Physical treatment for CTS in the last 6 months
- Cervical radiculopathy
- Tenosynovitis
- Peripheral polyneuropathy
- Another compressive neuropathy in the ipsilateral upper extremity
- History of trauma/fracture to the hand-wrist region
- Pregnancy
- Metabolic disease
- Rheumatic/autoimmune disease
- Kidney failure
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
March 3, 2026
First Posted
March 9, 2026
Study Start
March 1, 2026
Primary Completion (Estimated)
January 1, 2029
Study Completion (Estimated)
January 1, 2029
Last Updated
March 12, 2026
Record last verified: 2026-03